{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T20:08:17Z","timestamp":1783109297425,"version":"3.54.6"},"reference-count":29,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2008,12,23]],"date-time":"2008-12-23T00:00:00Z","timestamp":1229990400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transplant Infectious Dis"],"published-print":{"date-parts":[[2009,2]]},"abstract":"<jats:p><jats:bold>Abstract: <\/jats:bold> Antifungal prophylaxis for liver transplant recipients (LTRs) is common among patients considered at high risk of infection, but optimal prophylaxis duration and drug has not been defined. This study aimed to assess the effects of 14 days of antifungal therapy prophylaxis in reducing proven invasive fungal infections (IFI) in high\u2010risk subjects. Eligible subjects who met 2 or more risk criteria were randomized 1:1 to the treatment arms (liposomal amphotericin B or fluconazole) and were followed for 100 days post transplantation for evidence of IFI. The study was designed to enroll 300 subjects, but was closed early for insufficient enrollment. A total of 71 subjects were enrolled and randomized. Two\u2010thirds of subjects completed 14 days of study therapy. Ten subjects developed proven or probable IFI with <jats:italic>Candida<\/jats:italic> species (9 subjects) and <jats:italic>Cryptococcus neoformans<\/jats:italic> (1 subject); rates were similar in the 2 treatment arms. Eleven subjects died, but no death was attributed to study drug or IFI. In summary, high\u2010risk LTRs tolerated antifungal prophylaxis well, and rates of IFI were lower than previously reported in untreated high\u2010risk LTRs.<\/jats:p>","DOI":"10.1111\/j.1399-3062.2008.00361.x","type":"journal-article","created":{"date-parts":[[2008,12,24]],"date-time":"2008-12-24T03:45:50Z","timestamp":1230090350000},"page":"40-48","source":"Crossref","is-referenced-by-count":50,"title":["Outcomes of antifungal prophylaxis in high\u2010risk liver transplant recipients"],"prefix":"10.1111","volume":"11","author":[{"given":"S.","family":"Hadley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Huckabee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.G.","family":"Pappas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Daly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Rabkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.A.","family":"Kauffman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.M.","family":"Merion","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.W.","family":"Karchmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2009,1,21]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-198510000-00002"},{"key":"e_1_2_6_3_2","first-page":"132","article-title":"Infections after liver transplantation","volume":"67","author":"Kusne S","year":"1988","journal-title":"an analysis of 101 consecutive cases"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1001\/archsurg.1991.01410260033005"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1093\/clind\/16.5.677"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1399-3062.4.s3.3.x"},{"key":"e_1_2_6_7_2","first-page":"499","article-title":"Orthotopic liver transplantation in high\u2010risk patients","volume":"65","author":"Gayowski T","year":"1998","journal-title":"risk factors associated with mortality and infectious morbidity"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9610(00)00366-4"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/170.3.644"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00158579"},{"key":"e_1_2_6_11_2","first-page":"1328","article-title":"Bacterial and fungal infections after liver transplantation","volume":"21","author":"Wade JJ","year":"1995","journal-title":"an analysis of 284 patients"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-199610150-00010"},{"key":"e_1_2_6_13_2","first-page":"1195","article-title":"Prophylaxis with liposomal amphotericin B (AmBisome) prevents fungal infections in liver transplant recipients","volume":"27","author":"Tollemar J","year":"1995","journal-title":"long-term results of a randomized, placebo-controlled trial"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-131-10-199911160-00003"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-200209150-00017"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-199709150-00009"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-199503000-00009"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1086\/345441"},{"key":"e_1_2_6_19_2","first-page":"2023","article-title":"Changes in the spectrum and risk factors for invasive candidiasis in liver transplant recipients","volume":"75","author":"Husain S","year":"2003","journal-title":"prospective, multicenter, case-controlled study"},{"key":"e_1_2_6_20_2","first-page":"38","article-title":"Fungal infections complicating orthotopic liver transplantation","volume":"106","author":"Karchmer AW","year":"1995","journal-title":"Trans Am Clin Climatol Assoc"},{"key":"e_1_2_6_21_2","first-page":"386","article-title":"Invasive fungal infections in low\u2010risk liver transplant recipients","volume":"6","author":"Pappas PG","year":"2006","journal-title":"a multi-center prospective observational study"},{"key":"e_1_2_6_22_2","first-page":"7","article-title":"Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants","volume":"34","author":"Ascioglu S","year":"2002","journal-title":"an international consensus"},{"key":"e_1_2_6_23_2","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD004920","article-title":"Antifungal agents for preventing fungal infections in solid organ transpl recipients","author":"Playford EG","year":"2004","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1053\/jlts.2002.36239"},{"key":"e_1_2_6_25_2","first-page":"577","article-title":"Randomized double\u2010blind study of liposomal amphotericin B (AmBisome) prophylaxis of invasive fungal infections in bone marrow transplant recipients","volume":"12","author":"Tollemar J","year":"1993","journal-title":"Bone Marrow Transplant"},{"key":"e_1_2_6_26_2","first-page":"1204","article-title":"Selective decontamination of the digestive tract to prevent postoperative infection","volume":"30","author":"Zwaveling JH","year":"2002","journal-title":"a randomized placebo-controlled trial in liver transplant patients"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/174.3.583"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1053\/jlts.2000.7572"},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-199501150-00009"},{"key":"e_1_2_6_30_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000658-199601000-00010"}],"container-title":["Transplant Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1399-3062.2008.00361.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1399-3062.2008.00361.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,9]],"date-time":"2023-10-09T16:55:48Z","timestamp":1696870548000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1399-3062.2008.00361.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,1,21]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,2]]}},"alternative-id":["10.1111\/j.1399-3062.2008.00361.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1399-3062.2008.00361.x","archive":["Portico"],"relation":{},"ISSN":["1398-2273","1399-3062"],"issn-type":[{"value":"1398-2273","type":"print"},{"value":"1399-3062","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,1,21]]}}}